---
title: "White Paper - Breaking the CAPA Cycle: How to Stop Recurring Quality Events at the Root Cause"
description: The biotechnology industry plays a critical role in healthcare by advancing therapies through genetic research, biologics, and cell-based treatments
---

[![Dot Compliance logo](https://info.dotcompliance.com/hs-fs/hubfs/Dot%20Compliance%20Logo.png?width=1629&height=458&name=Dot%20Compliance%20Logo.png "Dot Compliance logo")](http://www.dotcompliance.com)

[![white-logo](https://f.hubspotusercontent40.net/hub/8124098/hubfs/Logo/white-logo.png?width=250&height=118&name=white-logo.png)](https://www.dotcompliance.com) [![Dot Compliance white one line](https://info.dotcompliance.com/hs-fs/hubfs/Dot%20Compliance%20white%20one%20line.png?width=250&height=60&name=Dot%20Compliance%20white%20one%20line.png) white-logo](https://www.dotcompliance.com)

## WHITEPAPER

# Breaking the CAPA Cycle: How to Stop Recurring Quality Events at the Root Cause

Life sciences organizations don't fail inspections because problems occur. They fail because the same problems keep coming back.

This white paper breaks down what separates a CAPA system that closes records from one that actually prevents recurrence, including the five core requirements every effective CAPA process must enforce, what FDA and ICH Q10 inspectors are really evaluating, and how automation and pattern detection strengthen root cause investigations. Learn how to move from reactive fire-fighting to proactive risk mitigation, and why the right CAPA management system makes all the difference for staying inspection-ready.

 

Please submit the form to download this whitepaper now.

Download Now

[![Dot Compliance white one line](https://info.dotcompliance.com/hs-fs/hubfs/Dot%20Compliance%20white%20one%20line.png?width=200&height=49&name=Dot%20Compliance%20white%20one%20line.png "Dot Compliance white one line")](https://www.dotcompliance.com)

Copyright © Dot Compliance 2026. All Rights Reserved.